Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLNC Cigarettes and Nicotine Patch for Smoking Cessation
NCT01050569Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Oct 2008
- Primary completion
- Dec 2011
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (3 arms), sponsored by University of Minnesota. Primary endpoints: End of Treatment Abstinence Rate at 12 weeks and End of Follow-up Abstinence Rates at 36 weeks. Started Oct 2008; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01050569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050569.